COMMUNIQUÉS West-GlobeNewswire

U.S. FDA Grants Fast Track Designation for BioCryst’s BCX7353
06/08/2018
RESEARCH TRIANGLE PARK, N.C., Aug. 06, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), a pharmaceutical company focused on the development and commercialization of treatments for rare diseases, [...]
C-RAD Web Presentation Half-Year Report 2018
06/08/2018
Presentation of the report for the first half of the fiscal year 2018: Date: Friday August 17, 2018 / kl. 11:00 Venue: Online Presentation Topic: C-RAD Half-Year Report 2018 Procedure: Please register online through the [...]
ASLAN Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update
06/08/2018
SINGAPORE, Aug. 06, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in [...]
Bio-on chooses Siemens control and supervisory systems to develop Industry 4.0 in the bioplastic sector
06/08/2018
Press Joint press release Siemens and Bio-On Milan, 06 August 2018 Bio-on's new production hub has begun producing bioplastic with a Siemens control and supervisory system The new Bio-on plant was created innovatively, [...]
Monthly information related to total number of voting rights and shares composing the share capital – July 31, 2018
06/08/2018
Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon - France ERN France, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Monthly information related to total number of voting rights and shares [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 31 juillet 2018
06/08/2018
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Lyon - France ERN France, 06 août 2018 (GLOBE NEWSWIRE) -- Information mensuelle relative au nombre total de droits de vote et d’actions composant [...]
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/08/2018
BURLINGTON, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to six new employees for an aggregate of 14,800 shares of common stock. [...]
SeaSpine Reports Granting of Inducement Awards
03/08/2018
CARLSBAD, Calif., Aug. 03, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced [...]
GBT Announces New Employment Inducement Grants
03/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that, on August 1, 2018, the compensation committee of the Company’s board of directors [...]
EyePoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/08/2018
WATERTOWN, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]
Acer Therapeutics Announces Closing of Underwritten Public Offering
03/08/2018
NEWTON, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare [...]
Advanced Proteome Therapeutics Announces Non-Brokered Private Placement
03/08/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“ APC ” or the “ [...]
California, Some Cities, Want to Ban Affordable Health Insurance, States the Association of American Physicians and Surgeons (AAPS)
03/08/2018
TUCSON, Ariz., Aug. 03, 2018 (GLOBE NEWSWIRE) -- The Trump Administration is liberalizing the rules to allow more people to have short-term, limited duration health insurance, but the rule is on a “crash course with a [...]
Melinta Therapeutics Announces Vabomere™ (meropenem and vaborbactam) Granted New Technology Add-On Payment by CMS
03/08/2018
Payment Will Reimburse up to 50% of Cost for Hospitals Treating Medicare Patients in Inpatient Setting NEW HAVEN, Conn., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage [...]
OPKO Health Completes Enrollment in Global Phase 3 Study of Somatrogon (hGH-CTP) in Growth Hormone Deficient Children
03/08/2018
MIAMI, Aug. 03, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) has completed enrollment in the Company’s global pivotal Phase 3 study in growth hormone deficient children, evaluating a single weekly injection [...]
CompactCath élargit son portefeuille de produits en introduisant des nouvelles sondes urinaires intermittentes discrètes, droites et coudées
03/08/2018
Les produits apportent un soulagement bienvenu aux utilisateurs autonomes quotidiens de sondes urinaires PALO ALTO, Californie, 03 août 2018 (GLOBE NEWSWIRE) -- CompactCath ( www.compactcath.com ), un fournisseur d' [...]
Draft decisions Joint Stock Company „Olainfarm” extraordinary General Meeting of shareholders to be held on September 04th, 2018
03/08/2018
Draft decisions Joint Stock Company „Olainfarm” extraordinary General Meeting of shareholders to be held on September 04th, 2018 1. Amendment of Statutes. 1.1. Initiate following amendments to the Statutes of the Joint [...]
Announcement About Convening of the Extraordinary General Meeting of Shareholders of Joint Stock Company “Olainfarm”
03/08/2018
Announcement About Convening of the Extraordinary General Meeting of Shareholders Joint Stock Company “Olainfarm” Management Board of the Joint Stock Company “Olainfarm”, unitary registration number. 40003007246, [...]
Affimed Announces Second Quarter 2018 Financial Results and Corporate Update Conference Call
03/08/2018
Heidelberg, Germany, August 3, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced that on August [...]

Pages